Morepen Laboratories P/E Ratio

MOREPENLAB • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
20.2
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 20.2
Current Price ₹37.81
EPS (TTM) ₹2.20
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 34.42
Historical Range 8.67 - 70.18
Percentile 25.0%

Sector Context

Sector Average 47.42
Sector Median 26.0
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹1.80
Sept 2025 ₹0.75
Mar 2025 ₹0.35

Key P/E Ratio Insights for Morepen Laboratories

  • Current PE is 41.3% below historical average
  • Trading at discount to sector average PE of 47.42

P/E Ratio Historical Trend for Morepen Laboratories

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 43.99 1.8 ₹79.19 NSE High
2024 20.54 2.39 ₹49.10 NSE Moderate
2023 24.03 1.5 ₹36.05 NSE Moderate
2022 65.92 0.87 ₹57.35 NSE High
2021 11.8 2.58 ₹30.45 NSE Low
2020 8.67 1.81 ₹15.70 NSE Low
2019 30.21 0.73 ₹22.05 NSE High
2018 70.18 0.56 ₹39.30 NSE High

Sector P/E Ratio Comparison

Comparing Morepen Laboratories with other companies in Healthcare sector
Sector Average
47.42
Sector Median
26.0
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.9 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.48 ₹1,128 Low
Amwill Health Care AMWILL 5.98 ₹61 Low
Medicamen Organics MEDIORG 6.37 ₹25 Low
Brooks Laboratories BROOKS 6.41 ₹127 Low
Unichem Laboratories UNICHEMLAB 7.14 ₹2,000 Low
Zenith Drugs ZENITHDRUG 7.28 ₹65 Low
Galaxy Medicare GML 7.77 ₹26 Low
Vasundhara Rasayans VRL 9.19 ₹34 Low